Ibrance (palbociclib) for the Treatment of Metastatic Breast Cancer

Ibrance (palbociclib) is an oral formulation developed by Pfizer for the treatment of metastatic breast cancer in women with disease progression post endocrine therapy.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news